Inventor · disambiguated record
Alessandro Sette
Also filed as: SETTE ALESSANDRO · SETTE ALESSANDRO D
44 granted patents·66 pending applications·1,869 citations·filing 1987–2024
98Inventor score
Files withEPIMMUNE INC16LA JOLLA INST ALLERGY & IMMUNOLOGY10PHARMEXA INC10LA JOLLA INST FOR IMMUNOLOGY8FIKES JOHN D7
Top patents by PatentIndex Score
110 records- 0197US6037135AMethods for making HLA binding peptides and their usesEPIMMUNE INC·Filed 1993·Granted Mar 14, 2000·308 cites·68 claims
- 0297US5736142AAlteration of immune response using pan DR-binding peptidesCYTEL CORP·Filed 1994·Granted Apr 7, 1998·300 cites·56 claims
- 0396US7026443B1Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2000·Granted Apr 11, 2006·92 cites·10 claims
- 0496US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0595US5662907AInduction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopesCYTEL CORP·Filed 1994·Granted Sep 2, 1997·187 cites·23 claims
- 0694US6534482B1Expression vectors for stimulating an immune response and methods of using the sameEPIMMUNE INC·Filed 1999·Granted Mar 18, 2003·155 cites·4 claims
- 0792US7888472B2Optimized multi-epitope constructs and uses thereofEPIMMUNE INC·Filed 2009·Granted Feb 15, 2011·12 cites·6 claims
- 0890US7462354B2Method and system for optimizing minigenes and peptides encoded therebyPHARMEXA INC·Filed 2001·Granted Dec 9, 2008·31 cites·20 claims
- 0990US6419931B1Compositions and methods for eliciting CTL immunityEPIMMUNE INC·Filed 1994·Granted Jul 16, 2002·94 cites·27 claims
- 1090US5750395ADNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptidesCYTEL CORP·Filed 1995·Granted May 12, 1998·73 cites·3 claims
- 1189US9913884B2HLA-A2 tumor associated antigen peptides and compositionsOSE PHARMA INT SA·Filed 2016·Granted Mar 13, 2018·13 cites·20 claims
- 1288US6413935B1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 1997·Granted Jul 2, 2002·73 cites·52 claims
- 1387US9340577B2HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2004·Granted May 17, 2016·21 cites·6 claims
- 1487US5679640AImmunosuppressant peptidesCYTEL CORP·Filed 1995·Granted Oct 21, 1997·89 cites·17 claims
- 1586US8007810B2HLA-A2 tumor associated antigen peptides and compositionsBIOTECH SYNERGY INC·Filed 2010·Granted Aug 30, 2011·11 cites·11 claims
- 1684US7202351B1Alteration of immune response using pan DR-binding peptidesPHARMEXA INC·Filed 2000·Granted Apr 10, 2007·20 cites·14 claims
- 1784US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 1883US7572882B2Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2000·Granted Aug 11, 2009·6 cites·13 claims
- 1982US5200320AMethod for identifying useful polypeptide vaccinesNAT JEWISH CT IMMUN & RESPIRAT·Filed 1987·Granted Apr 6, 1993·57 cites·2 claims
- 2079US6413517B1Identification of broadly reactive DR restricted epitopesEPIMMUNE INC·Filed 1998·Granted Jul 2, 2002·40 cites·2 claims
- 2178US7507803B2Optimized multi-epitope constructs and uses thereofGENIMMUNE N V·Filed 2003·Granted Mar 24, 2009·7 cites·4 claims
- 2277US10703784B2Antigens and epitopes derived from Mycobacterium tuberculosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2012·Granted Jul 7, 2020·2 cites·6 claims
- 2376US8741576B2Heteroclitic analogs and related methodsTANGRI SHABNAM·Filed 2002·Granted Jun 3, 2014·18 cites·12 claims
- 2476US6464980B1MAGE-1 c-terminal immunogenic peptidesEPIMMUNE INC·Filed 1996·Granted Oct 15, 2002·23 cites·5 claims
- 2572US10308689B2Dengue virus (DV) polypeptide sequences, T cell epitopes and methods and uses thereofLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Jun 4, 2019·2 cites·8 claims
- 2672US9394350B2HLA-A2 tumor associated antigen peptides and compositionsFIKES JOHN D·Filed 2013·Granted Jul 19, 2016·3 cites·11 claims
- 2772US7611713B2Inducing cellular immune responses to hepatitis B virus using peptide compositionsPHARMEXA INC·Filed 2003·Granted Nov 3, 2009·5 cites·5 claims
- 2871US8017745B2Plasmodium falciparum antigens and methods of useEPIMMUNE INC·Filed 2003·Granted Sep 13, 2011·3 cites·38 claims
- 2971US7252829B1HLA binding peptides and their usesIDM PHARMA INC·Filed 1998·Granted Aug 7, 2007·30 cites·3 claims
- 3070US6156316AOncogene fusion protein peptide vaccinesSLOAN KETTERING INST CANCER·Filed 1995·Granted Dec 5, 2000·24 cites·8 claims
- 3168US12448433B2Human ApoB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2021·Granted Oct 21, 2025·0 cites·13 claims
- 3266US2009012004A1HLA binding peptides and their usesIDM PHARMA INC·Filed 2007·Application pending·0 cites
- 3365US2009214632A1Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2008·Application pending·0 cites
- 3464US2024294900A1Common Cold Coronavirus T Cell Epitopes, Methods and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2024·Application pending·0 cites
- 3564US2008279924A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2007·Application pending·0 cites
- 3663US10059751B2Peptide combinations and uses thereof in treating dust mite allergyALK ABELLO AS·Filed 2014·Granted Aug 28, 2018·1 cites·15 claims
- 3762US10428124B2Timothy grass allergens and methods and uses for immune response modulationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2013·Granted Oct 1, 2019·1 cites·5 claims
- 3860US2003216342A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 3960US2007098776A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2006·Application pending·0 cites
- 4060US2010049491A1Method and System for Optimizing Minigenes and Peptides Encoded TherebySETTE ALESSANDRO·Filed 2008·Application pending·0 cites
- 4160US2003216343A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 4259US2010068228A1Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsPHARMEXA INC·Filed 2009·Application pending·0 cites
- 4358US2025341513A1Bordetella T Cells Epitopes, Megapools and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 4458US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 4558US2020123213A1Immunogenic proteins and fragments thereof from allergenic mitesALK ABELLO AS·Filed 2019·Application pending·0 cites
- 4657US2002160960A1HLA binding peptides and their usesFiled 2002·Application pending·0 cites
- 4757US2011150914A1Compositions and methods for dengue virus (dv) treatment and vaccinationJOLLA INST ALLERGY IMMUNOLOG·Filed 2009·Application pending·0 cites
- 4856US10918713B2Epitopes from allergen proteins and methods and uses for immune response modulationLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 4955US10556936B2Immunogenic proteins and fragments thereof from allergenic mitesALK ABELLO AS·Filed 2017·Granted Feb 11, 2020·0 cites·11 claims
- 5055US2004157780A1CTL inducing peptides from c-erb2 (HER-2/neu)EPIMMUNE INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 110 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alessandro Sette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →